HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: jmg.2006.042473v1 44/1/e59    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Johnston, J. J Articles by Biesecker, L. G Search for Related Content PubMed PubMed Citation Articles by Johnston, J. J Articles by Biesecker, L. G Pubmed/NCBI databases Medline Plus Health Information Facial Injuries and Disorders Head and Brain Malformations Genetics Home Reference

Zoom-in comparative genomic hybridisation arrays for the characterisation of variable breakpoint contiguous gene syndromes

¹ National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
² Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
³ Shriners Hospital of Northern California, Sacramento, California, USA
⁴ Department of Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA

Correspondence to:
Dr J J Johnston
Room 4C72, 49 Convent Drive, Bethesda, MD 20892, USA; jjohnsto{at}mail.nih.gov] Contiguous gene syndromes cause disorders via haploinsufficiency for adjacent genes. Some contiguous gene syndromes (CGS) have stereotypical breakpoints, but others have variable breakpoints. In CGS that have variable breakpoints, the extent of the deletions may be correlated with severity. The Greig cephalopolysyndactyly contiguous gene syndrome (GCPS-CGS) is a multiple malformation syndrome caused by haploinsufficiency of GLI3 and adjacent genes. In addition, non-CGS GCPS can be caused by deletions or duplications in GLI3. Although fluorescence in situ hybridisation (FISH) can identify large deletion mutations in patients with GCPS or GCPS-CGS, it is not practical for identification of small intragenic deletions or insertions, and it is difficult to accurately characterise the extent of the large deletions using this technique. We have designed a custom comparative genomic hybridisation (CGH) array that allows identification of deletions and duplications at kilobase resolution in the vicinity of GLI3. The array averages one probe every 730 bp for a total of about 14 000 probes over 10 Mb. We have analysed 16 individuals with known or suspected deletions or duplications. In 15 of 16 individuals (14 deletions and 1 duplication), the array confirmed the prior results. In the remaining patient, the normal CGH array result was correct, and the prior assessment was a false positive quantitative polymerase chain reaction result. We conclude that high-density CGH array analysis is more sensitive than FISH analysis for detecting deletions and provides clinically useful results on the extent of the deletion. We suggest that high-density CGH array analysis should replace FISH analysis for assessment of deletions and duplications in patients with contiguous gene syndromes caused by variable deletions.

Abbreviations: CGH, comparative genomic hybridisation; CGS, contiguous gene syndrome; FISH, fluorescence in situ hybridisation; GCPS, Greig cephalopolysyndactyly; qPCR, quantitative polymerase chain reaction

Keywords: GLI3; oligonucleotide array; comparative genomic hybridization